Title:
CONTRACEPTIVE METHODS WITH SCHEDULED BLEEDING EFFECTS
Document Type and Number:
WIPO Patent Application WO/2023/152682
Kind Code:
A9
Abstract:
Described are methods of providing contraception with increased likelihood of scheduled bleeding in a woman having a BMI < 30.0 kg/m2 and methods of providing contraception with reduced likelihood of scheduled bleeding in a woman having a BMI ≥ 30.0 kg/m2. The methods comprise orally administering a therapeutically effective amount of an estetrol component at a daily dose of from 14 mg to 16 mg, based on the estetrol moiety, and drospirenone at a daily dose of from 2.5 mg to 3.5 mg. Also provided are compositions comprising an estetrol component and drospirenone for use in such methods.
Inventors:
FOIDART JEAN-MICHEL (BE)
JOST MAUD (BE)
JOST MAUD (BE)
Application Number:
PCT/IB2023/051177
Publication Date:
February 29, 2024
Filing Date:
February 09, 2023
Export Citation:
Assignee:
ESTETRA SRL (BE)
International Classes:
A61K31/565; A61K31/585; A61P15/18
Download PDF:
Previous Patent: AR TECHNOLOGY BASED DECORATION SYSTEMS AND METHODS
Next Patent: SECONDARY NODE INITIATED CONDITIONAL PSCELL CHANGE
Next Patent: SECONDARY NODE INITIATED CONDITIONAL PSCELL CHANGE